BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24074388)

  • 1. Gateway to understanding microparticles: standardized isolation and identification of plasma membrane-derived vesicles.
    Dinkla S; Brock R; Joosten I; Bosman GJ
    Nanomedicine (Lond); 2013 Oct; 8(10):1657-68. PubMed ID: 24074388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
    Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
    Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
    Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
    Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell PMVs, plasma membrane-derived vesicles calling out for standards.
    Hind E; Heugh S; Ansa-Addo EA; Antwi-Baffour S; Lange S; Inal J
    Biochem Biophys Res Commun; 2010 Sep; 399(4):465-9. PubMed ID: 20674549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study.
    Engelmann C; Splith K; Krohn S; Herber A; Boehlig A; Boehm S; Pratschke J; Berg T; Schmelzle M
    J Transl Med; 2017 Sep; 15(1):188. PubMed ID: 28877719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles in cardiovascular disease pathophysiology and outcomes.
    Viera AJ; Mooberry M; Key NS
    J Am Soc Hypertens; 2012; 6(4):243-52. PubMed ID: 22789878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Characterization of Circulating Microparticles by Flow Cytometry.
    Burger D; Oleynik P
    Methods Mol Biol; 2017; 1527():271-281. PubMed ID: 28116723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct proteome features of plasma microparticles.
    Jin M; Drwal G; Bourgeois T; Saltz J; Wu HM
    Proteomics; 2005 May; 5(7):1940-52. PubMed ID: 15825151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of pro-coagulant microparticles after moderate endurance exercise.
    Sossdorf M; Otto GP; Claus RA; Gabriel HH; Lösche W
    Platelets; 2010; 21(5):389-91. PubMed ID: 20377328
    [No Abstract]   [Full Text] [Related]  

  • 15. Microparticle and Atherothrombotic Diseases.
    Nomura S
    J Atheroscler Thromb; 2016; 23(1):1-9. PubMed ID: 26412494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo.
    Einfinger K; Badrnya S; Furtmüller M; Handschuh D; Lindner H; Geiger M
    PLoS One; 2015; 10(11):e0143137. PubMed ID: 26580551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microparticles are elevated in carriers of factor V Leiden.
    Enjeti AK; Lincz LF; Scorgie FE; Seldon M
    Thromb Res; 2010 Sep; 126(3):250-3. PubMed ID: 20022357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report.
    Robert S; Lacroix R; Poncelet P; Harhouri K; Bouriche T; Judicone C; Wischhusen J; Arnaud L; Dignat-George F
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1054-8. PubMed ID: 22328775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects.
    Soop A; Hållström L; Frostell C; Wallén H; Mobarrez F; Pisetsky DS
    Scand J Immunol; 2013 Aug; 78(2):205-13. PubMed ID: 23679665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Super-resolved calibration-free flow cytometric characterization of platelets and cell-derived microparticles in platelet-rich plasma.
    Konokhova AI; Chernova DN; Moskalensky AE; Strokotov DI; Yurkin MA; Chernyshev AV; Maltsev VP
    Cytometry A; 2016 Feb; 89(2):159-68. PubMed ID: 25808430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.